EP 0675731 A1 19951011 - TREATMENT OF CYTOMEGALOVIRUS INFECTION.
Title (en)
TREATMENT OF CYTOMEGALOVIRUS INFECTION.
Title (de)
BEHANDLUNG VOM CYTOMEGALOVIRUSINFEKTIONEN.
Title (fr)
TRAITEMENT DE L'INFECTION PROVOQUEE PAR LE CYTOMEGALOVIRUS.
Publication
Application
Priority
- CA 9400590 W 19941021
- US 13975793 A 19931022
Abstract (en)
[origin: WO9511038A1] Described herein are anti-cytomegalovirus peptides. In a preferred embodiment, the peptide is acetyl-[D-Arg]9-NH2. The use of these peptides, either per se or in combination with other anti-CMV compounds, is disclosed as an effective method for controlling CMV infection.
IPC 1-7
IPC 8 full level
A61K 38/08 (2019.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP US)
A61K 38/08 (2013.01 - EP US); C07K 7/06 (2013.01 - EP); C07K 7/08 (2013.01 - EP)
Citation (search report)
See references of WO 9511038A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9511038 A1 19950427; AU 685862 B2 19980129; AU 7987694 A 19950508; CA 2152373 A1 19950427; CA 2152373 C 19981215; EP 0675731 A1 19951011
DOCDB simple family (application)
CA 9400590 W 19941021; AU 7987694 A 19941021; CA 2152373 A 19941021; EP 94930888 A 19941021